Actover Group, in collaboration with its pharmaceutical subsidiaries Acteropharma, Atipharmed and Nexus, as well as the EIN beauty and personal care brand, organized a community walk to raise awareness of breast cancer and promote women’s health.
According to Actover Group’s Public Relations Department, the event brought together participants, physicians and pharmacists from across the Group to highlight the importance of early detection and timely treatment of breast cancer. Attendees also received information about breast cancer risk factors, warning signs, self-examination and diagnostic methods.
Early Detection: A Key Step in Combating Breast Cancer
During the event, Dr. Keynoosh Fooladi, Oncology Medical Advisor at Actoverco, highlighted the prevalence of breast cancer worldwide. She noted that breast cancer is the most common cancer among women globally and the leading cause of cancer-related deaths among Iranian women.
According to Dr. Fooladi, approximately one in eight women will develop breast cancer during their lifetime, with the risk increasing with age. In Iran, the most common age range for diagnosis is between 45 and 55.
She also emphasized that breast cancer is not exclusive to women, as approximately 0.5 to 1 percent of cases occur in men. However, limited awareness of this fact can contribute to delayed diagnosis and treatment among male patients.
Dr. Fooladi identified several factors associated with an increased risk of breast cancer, including a family history of the disease, known genetic mutations in individuals or their families, older age, certain hormonal conditions, a personal history of breast or ovarian cancer, and exposure to chest radiation at a young age.
She further noted that factors such as having no history of pregnancy or breastfeeding, physical inactivity, obesity, alcohol and tobacco consumption, high breast density, and exposure to certain environmental factors, including ionizing radiation, may also be considered when assessing breast cancer risk.
Atipharmed: Dedicated to Women’s Health at Every Stage of Life
In another segment of the event, Dr. Nafiseh Ghaffar Natanzi, Medical Advisor at Atipharmed, discussed the company’s focus on developing and manufacturing hormonal medicines related to women’s health.
She explained that Atipharmed was established in 2011 and, since 2017, has operated as the first Iranian pharmaceutical company to receive GMP certification for the production of sex hormone medications, utilizing technology transferred from one of Europe’s largest pharmaceutical companies.
She added that the company’s activities address women’s pharmaceutical needs at different stages of life, from early adolescence and the onset of menstruation through menopause.
Referring to the physical symptoms and mood fluctuations associated with premenstrual syndrome (PMS), menstruation and menopause, Dr. Ghaffar Natanzi noted that these conditions can cause a range of challenging symptoms. However, various pharmaceutical treatment options are available to help alleviate and manage some of these symptoms. With appropriate treatment and medical consultation, these options can contribute to improving women’s quality of life.
Actover Group Supports Breast Cancer Patients Through Charitable Donation
As part of the event, companies within Actover Group presented symbolic donation checksto the Dr. Mostafa Naraghi Charity to support the treatment and care of breast cancer patients. The financial contribution will be allocated to helping patients access the treatment they need.
Participants also received specially curated packages containing pharmaceutical supplements from Nexus and personal care and hygiene products from EIN. Interactive activities throughout the event further encouraged participants to engage in a shared experience centered on self-care, health awareness and well-being.
The event forms part of Actover Group’s ongoing Corporate Social Responsibility (CSR) initiatives, reflecting its commitment to promoting a culture of prevention, early diagnosis and greater attention to public health, with a particular focus on raising awareness of breast cancer.
